You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 296 HER2-specific highly scalable CAR NK cell (anti-HER2-CAR SNK02) exhibits a significantly enhanced antitumor activity against HER2-expressing tumors as an off-the-shelf allogeneic immune cell therapy

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
296 HER2-specific highly scalable CAR NK cell (anti-HER2-CAR SNK02) exhibits a significantly enhanced antitumor activity against HER2-expressing tumors as an off-the-shelf allogeneic immune cell therapy

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023352034
Dec 202363010
Jan 20244002
Feb 20247003
Mar 2024144013
Apr 20248203
May 20248004
Jun 20245804
Jul 2024116013
Aug 20243803
Sep 20247006
Oct 202480017
Nov 2024140016
Dec 20244208
Jan 20254409
Feb 20251005
Mar 20250016
Apr 2025005
May 20250011
Jun 2025108
Total14300190